Blake Turvey, MD
Orthopaedic Trauma · Austin, TXNPI 1528417698
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (36.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Stryker at 38.9% of the total. Reporting peaked in 2023 at $6,090 and has fallen 50.1% since, to $3,041 in 2025. That places this record below the midpoint for orthopaedic trauma clinicians in TX, where the typical reported total is $14,950.
Across 119 payments — averaging $116.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$5K
- Acumed LLC$4K
- Core Surgical Group$1K
- Medinc Of Texas$1K
- Arthrex$615
- Medical Device Business Services, Inc.$500
- plus $988 from 6 others
What the payments were for
- Consulting fees$2,21316%
- Grants$9507%
- Travel & lodging$5,12437%
- Food & beverage$4,38932%
- Education$1,2009%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 51 | $5,399 |
| Acumed LLC | 19 | $3,786 |
| Core Surgical Group | 7 | $1,328 |
| Medinc Of Texas | 2 | $1,259 |
| Arthrex | 9 | $615 |
| Medical Device Business Services, Inc. | 1 | $500 |
| Johnson & Johnson | 14 | $302 |
| Zimmer Biomet | 6 | $280 |
| Smith+Nephew | 5 | $186 |
| Sanara Medtech Inc. | 1 | $108 |
| Orthofix Medical, Inc. | 1 | $67 |
| Ossur Americas, Inc. | 3 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACUMED$5,660
- MAKO$2,689
- OsteoMed$1,061
- PRO$427
- INFINITY$328
- OMEGA$322
- ORTHOLOC 2 LAPIFUSE$174
- FIXOS$174
- BIO4$174
- GAMMA$173
- CITREFIX$164
- Actishield$164
- T2$162
- SONICANCHOR$158
- VARIAX$158
- HOFFMANN$158
- EVOS$122
- Alps Plates and Instruments$111
- Biasurge$108
How this compares
$13,876 in reported general payments places this provider in the 45th percentile of 74 orthopaedic trauma providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 38 | $1,064 |
| Oxycodone Hcl | 75 | $461 |
| Ibuprofen | 30 | $273 |
| Gabapentin | 30 | $260 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $215 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $201 |
| Meloxicam | 47 | $173 |
| Methocarbamol | 17 | $173 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $98 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $70 |
| Tramadol Hcl | 12 | $45 |
| Cyclobenzaprine Hcl | 13 | $39 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Austin
- Blake SchultzAustin$37K
- Vilas SaldanhaAustin$25K
- Mark ParrellaAustin$21K
- David LavertyAustin$17K
- Austin HillAustin$10K
- Cody AndersonAustin$3K
- Cory CollingeFort Worth$2.8M
- John MunzHouston$1M
- Kyle DicksonHouston$975K
- Timothy AchorHouston$561K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.